aspirin has been researched along with adenosine monophosphate in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (15.15) | 18.7374 |
| 1990's | 3 (4.55) | 18.2507 |
| 2000's | 25 (37.88) | 29.6817 |
| 2010's | 19 (28.79) | 24.3611 |
| 2020's | 9 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Tsukada, T | 1 |
| Jobin, F | 1 |
| Han, GY; Han, PF; Johnson, J; McBay, HC | 1 |
| Ts'ao, C | 1 |
| Jörgensen, TG; Olesen, HP; Weis-Fogh, US | 1 |
| Fiegler, M; Jávor, T; Mózsik, G; Nagy, L; Patty, I; Tárnok, F | 1 |
| Parisi, M; Piccinni, ZF | 1 |
| Day, HJ; Holmsen, H; Setkowsky, CA | 1 |
| Crutchley, DJ; Ryan, JW; Ryan, US | 1 |
| Hayashi, K; Kawasaki, T; Miyoshi, A; Ohe, K; Shirakawa, T; Yamada, K | 1 |
| Crimi, N; Magrì, S; Milazzo, VL; Mistretta, A; Polosa, R; Prosperini, G; Santonocito, G | 1 |
| Bakker, WW; Cheung, PK; Visser, J | 1 |
| Knox, A; Pavord, I; Tattersfield, A; Wang, M; Wisniewski, A | 1 |
| Cameron, KE; Heptinstall, S; May, JA; Sanderson, HM; Storey, RF; White, AE | 1 |
| Oldroyd, KG; Storey, RF; Wilcox, RG | 1 |
| Bath, P; Heptinstall, S; Zhao, L | 1 |
| Heptinstall, S; Judge, HM; Storey, RF; Wilcox, RG | 1 |
| Bath, PM; Fox, S; Heptinstall, S; Judge, H; Lösche, W; May, J; Zhao, L | 1 |
| Grieco, G; Jonas, S | 1 |
| Graff, J; Harder, S; Klinkhardt, U | 1 |
| Battastini, AM; Buffon, A; Fürstenau, CR; Ribeiro, VB; Sarkis, JJ | 1 |
| Heptinstall, S; May, JA; Storey, RF | 1 |
| Fälker, K; Lange, D; Presek, P | 1 |
| Graff, J; Harder, S | 1 |
| Buckland, RJ; Holgate, CE; Judge, HM; Storey, RF | 1 |
| Gurbel, PA; Tantry, US | 1 |
| Brandl, R; Deckmyn, H; Penz, SM; Reininger, AJ; Siess, W; Toth, O | 1 |
| Fox, SC; Heptinstall, S; White, AE; Wilcox, RG; Xavier, RG | 1 |
| Barker, CM; Price, MJ | 1 |
| Angiolillo, DJ; Guzman, LA | 1 |
| Bagatini, MD; Battisti, V; dos Santos, RB; Gasparetto, D; Gonçalves, JF; Martins, CC; Morsch, VM; Rosa, CS; Schetinger, MR; Spanevello, RM | 1 |
| Eikelboom, JW; Hirsh, J; Raju, NC | 1 |
| Béres, BJ; Kerecsen, G; Kiss, RG; László, A; Masszi, T; Préda, I; Tóth-Zsámboki, E; Vargová, K | 1 |
| Dovlatova, N; Espinosa, DI; Fox, SC; Glenn, JR; Gurney, M; Hartman, D; Heptinstall, S; Hermann, D; Johnson, A; Magnusson, O; Manolopoulos, P; May, JA; Stefansson, K; White, AE | 1 |
| Moliterno, DJ | 1 |
| Karhunen, PJ; Lassila, R; Lepäntalo, A; Mikkelsson, J; Reséndiz, JC; Viiri, LE; Virtanen, KS | 1 |
| Butt, M; Lip, GY; Shantsila, E; Siddique, A | 1 |
| Fox, SC; Heptinstall, S; May, JA; Neubert, U; Shah, A | 1 |
| Frey, N; Ivandic, B | 1 |
| Ağırbaşlı, M; Cinçin, A; Güvenç, H | 1 |
| Dovlatova, N; Fox, SC; Glenn, JR; Heptinstall, S; Iyú, D; White, AE | 1 |
| Moliterno, DJ; Rajan, L | 1 |
| Caglayan, E; Er, F; Erdmann, E; Gassanov, N | 1 |
| Contractor, H; Ruparelia, N | 1 |
| Dibattiste, PM; Ringwala, SM; Schneider, DJ | 1 |
| Lavi, R; Lavi, S | 1 |
| Angiolillo, DJ; Cho, JR; Franchi, F; Muñiz-Lozano, A; Rollini, F | 1 |
| Dobesh, PP; Oestreich, JH | 1 |
| Anderson, JL; Bates, ER; Bode, C; Granger, CB; Huber, K; Kristensen, SD; Lopez Sendon, JL; Ohman, EM; Steg, PG; Tubaro, M; Valgimigli, M; Wallentin, L | 1 |
| Cooke, NM; Kenny, D; O'Leary, J; Sheils, O; Spillane, CD | 1 |
| Angiolillo, DJ; Franchi, F; Park, Y; Rollini, F | 1 |
| Frelinger, AL; Gremmel, T; Michelson, AD; Przyklenk, K; Undyala, VV; Wider, J; Wright, GE; Yanachkov, IB; Yanachkova, MI | 1 |
| Burris, RJ; Seto, AH; Tyler, JM | 1 |
| Calnan, MW; Crawford, AN | 1 |
| Farag, M; Gorog, DA; Gue, YX; Spinthakis, N; Srinivasan, M; Wellsted, DM | 1 |
| Aghaebrahim, A; Agnoletto, GJ; Aguilar-Salinas, P; Brasiliense, LBC; Gonsales, D; Granja, MF; Hanel, RA; Santos, R; Sauvageau, E | 1 |
| Banerjee, S; Baskar, A; Chauhan, S; Cui, Z; Dargham, BB; Sum-Ping, J; Tejani, I; Weideman, RA | 1 |
| Dagois, S; De Mesmay, M; Devys, JM; Dupont, C; Godier, A; Mazighi, M; Mesnil, M; Thion, LA | 1 |
| Abdennour, L; Bernard, R; Carpentier, A; Clarençon, F; Degos, V; Drir, M; Godier, A; Lenck, S; Mathout, J; Premat, K; Shotar, E; Sourour, N; Taylor, G | 1 |
| Bozzi, S; Cattaneo, M; Mencarini, T; Podda, G; Redaelli, A; Scavone, M | 1 |
| Finniss, M; Helton, T; Khalid, M; Khan, AA; Murtaza, G | 1 |
| Aknouche, S; Allard, J; Blanc, R; Ciccio, G; Delvoye, F; Desilles, JP; Escalard, S; Hebert, S; Labreuche, J; Maertens de Noordhout, A; Maier, B; Mazighi, M; Obadia, M; Olivot, JM; Piotin, M; Redjem, H; Sabben, C; Smajda, S; Thion, LA | 1 |
| Amini, H; Azhdari Tehrani, H; Haji Aghajani, M; Moradi, O; Pourheidar, E; Rabiei, MM; Sistanizad, M | 1 |
| Brandt, C; Deinhardt-Emmer, S; Doshi, H; Ehrhardt, C; Giebeler, L; Häring, C; Jungwirth, J; König, S; Löffler, B | 1 |
| Askaryar, S; Grossman, D; Liu, T; Rahman, H | 1 |
| Calleris, G; Cedrone, M; Ceraolo, E; Gontero, P; Rosboch, GL | 1 |
17 review(s) available for aspirin and adenosine monophosphate
| Article | Year |
|---|---|
Acetylsalicylic acid, hemostasis and human thromboembolism.
Topics: Adenosine Monophosphate; Aspirin; Blood Coagulation Tests; Blood Platelets; Cardiac Catheterization; Cerebrovascular Disorders; Complement System Proteins; Coronary Disease; Dose-Response Relationship, Drug; Fibrinolysis; Guanosine Monophosphate; Heart Valve Prosthesis; Hemostasis; Humans; Platelet Adhesiveness; Platelet Aggregation; Prostaglandins; Thromboembolism | 1978 |
Potential value of triple antiplatelet therapy for secondary stroke prevention.
Topics: Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk; Stroke; Treatment Outcome | 2003 |
Aspirin and clopidogrel resistance: consideration and management.
Topics: Adenosine; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Restenosis; Drug Resistance; Humans; Membrane Proteins; Myocardial Ischemia; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Ticagrelor; Ticlopidine | 2006 |
Clinical overview of promising nonthienopyridine antiplatelet agents.
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Coronary Disease; Drug Therapy, Combination; Humans; Lactones; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Receptors, Thrombin; Ticagrelor | 2008 |
Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future.
Topics: Adenosine; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; History, 20th Century; History, 21st Century; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stents; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome | 2008 |
Advances in antiplatelet therapy for ACS and PCI.
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Angina, Unstable; Aspirin; Blood Platelets; Cardiac Catheterization; Fibrinolytic Agents; Humans; Lactones; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyridines; Treatment Outcome | 2008 |
New antiplatelet drugs: beyond aspirin and clopidogrel.
Topics: Adenosine; Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Drug Design; Humans; Imines; Lactones; Naphthalenes; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Propionates; Purinergic P2 Receptor Antagonists; Pyridines; Thiophenes; Ticagrelor; Ticlopidine | 2009 |
[New approaches and indications for the analysis of platelet function in cardiology].
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Interactions; Hemorrhage; Humans; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
[Novel agents in antiplatelet therapy].
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Humans; Lactones; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Thiophenes; Ticagrelor; Ticlopidine | 2010 |
Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS?
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Quinazolinones; Receptors, Purinergic P2Y12; Sulfonamides; Tetrazoles; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
[ADP receptor blockers: new insights in the therapy and prophylaxis of ischemic heart disease].
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Pyridines; Receptors, Purinergic P2; Stents; Ticlopidine | 2011 |
Advances in antiplatelet therapy for acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Emergency Treatment; Female; Humans; Male; Patient Selection; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Quinazolinones; Sulfonamides; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome | 2012 |
Perioperative management of antiplatelet agents in patients undergoing cardiac surgery.
Topics: Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Coronary Artery Bypass; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticagrelor; Ticlopidine | 2012 |
Cangrelor: a review on pharmacology and clinical trial development.
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Animals; Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists | 2013 |
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Fondaparinux; Heparin; Hirudins; Humans; Lactones; Peptide Fragments; Peptides; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Recombinant Proteins; Thiophenes; Ticagrelor; Tirofiban; Tyrosine; Warfarin | 2014 |
A Safety Evaluation of Cangrelor in Patients Undergoing PCI.
Topics: Adenosine Monophosphate; Aspirin; Drug Interactions; Drug Therapy, Combination; Half-Life; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists | 2016 |
Why we need intravenous antiplatelet agents.
Topics: Adenosine Monophosphate; Aspirin; Blood Platelets; Humans; Injections, Intravenous; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists | 2016 |
4 trial(s) available for aspirin and adenosine monophosphate
| Article | Year |
|---|---|
Inhaled lysine acetylsalicylate (L-ASA) attenuates the bronchoconstrictor response to adenosine 5'-monophosphate (AMP) in asthmatic subjects.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Interactions; Female; Histamine; Humans; Lysine; Male; Methacholine Chloride; Middle Aged; Respiratory Function Tests | 1995 |
Comparison of three inhaled non-steroidal anti-inflammatory drugs on the airway response to sodium metabisulphite and adenosine 5'-monophosphate challenge in asthma.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Double-Blind Method; Female; Humans; Hydrogen-Ion Concentration; Indomethacin; Lung; Lysine; Male; Middle Aged; Osmolar Concentration; Sodium Salicylate; Sulfites | 1996 |
Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes.
Topics: Acute Disease; Adenosine Monophosphate; Adult; Aged; Angina, Unstable; Aspirin; Blood Coagulation Tests; Consumer Product Safety; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Heparin; Humans; Male; Membrane Proteins; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12 | 2001 |
Effects on platelet function of a direct acting antagonist of coagulation factor Xa.
Topics: Adenosine Monophosphate; Aged; Anticoagulants; Aspirin; Blood Platelets; Coronary Artery Disease; Crotalid Venoms; Factor Xa; Factor Xa Inhibitors; Female; Humans; Lectins, C-Type; Male; Middle Aged; Morpholines; Plant Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Rivaroxaban; Thiophenes | 2012 |
45 other study(ies) available for aspirin and adenosine monophosphate
| Article | Year |
|---|---|
Platelet retention in glass bead columns: its mechanism and the effect of plasma proteins.
Topics: Adenosine; Adenosine Monophosphate; Animals; Aspirin; Cattle; Female; Fibrinogen; gamma-Globulins; Heparin; Humans; In Vitro Techniques; Male; Platelet Adhesiveness; Serum Albumin | 1976 |
Alteration of the regulatory properties of chicken liver fructose-1,6-bisphosphatase by treatment with aspirin.
Topics: Adenosine Monophosphate; Animals; Aspirin; Chickens; Fructose-Bisphosphatase; Kinetics; Liver | 1978 |
Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Apyrase; Aspirin; Blood Platelets; Collagen; Female; Humans; Male; Platelet Aggregation; Rats | 1976 |
The influence of acetylsalicylic acid (aspirin) on gastric mucosal content of energy-rich phosphate bond.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Aspirin; Female; Gastric Mucosa; Male; Swine | 1976 |
Biochemical background of the development of gastric mucosal damage in pylorus-ligated plus aspirin-treated rats.
Topics: Absorption; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Aspirin; Cyclic AMP; Energy Metabolism; Female; Gastric Emptying; Gastric Juice; Gastric Mucosa; Hydrogen-Ion Concentration; Lactates; Ligation; Male; Rats; Stomach Ulcer | 1986 |
Aspirin potentiates the hydrosmotic effect of antidiuretic hormone in toad urinary bladder.
Topics: Adenosine Monophosphate; Animals; Anura; Aspirin; Cell Membrane Permeability; Depression, Chemical; Drug Synergism; Oxytocin; Prostaglandin Antagonists; Stimulation, Chemical; Urinary Bladder; Vasopressins; Water-Electrolyte Balance | 1972 |
Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline.
Topics: Adenine; Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Aspirin; Blood Coagulation; Blood Platelets; Carbon Isotopes; Cattle; Collagen; Epinephrine; Glycolysis; Horses; Humans; Hypoxanthines; In Vitro Techniques; Inosine Nucleotides; Oxidative Phosphorylation; Thrombin; Tritium | 1972 |
Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Aspirin; Cattle; Cells, Cultured; Dipyridamole; Platelet Aggregation; Pulmonary Artery | 1980 |
Aspirin- and taurocholate-induced metabolic damage in mammalian gastric mucosa in vitro.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Aspirin; Energy Metabolism; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Guinea Pigs; Taurocholic Acid | 1980 |
Upregulation of antithrombotic ectonucleotidases by aspirin in human endothelial cells in-vitro.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Apyrase; Aspirin; Cells, Cultured; Chromatography, High Pressure Liquid; Endothelium, Vascular; Fluorescein-5-isothiocyanate; Humans; Spectrometry, Fluorescence; Umbilical Veins; Up-Regulation | 1994 |
The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Monophosphate; Analysis of Variance; Annexin A5; Aspirin; Blood Platelets; Calcium; Collagen; Cytosol; Fibrinolytic Agents; Flow Cytometry; Humans; Membrane Proteins; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Serotonin; Stimulation, Chemical; Thromboxane A2 | 2000 |
Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Communication; Dipyridamole; Drug Synergism; Flow Cytometry; Humans; Leukocytes; Macrophage-1 Antigen; Monocytes; Neutrophils; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors | 2001 |
Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Adhesion; Clopidogrel; Drug Therapy, Combination; Female; Humans; Leukocytes; Male; Membrane Proteins; Middle Aged; Myocardial Ischemia; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Ticlopidine | 2002 |
The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions.
Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD11b Antigen; Dipyridamole; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Leukocytes; Monocytes; Neutrophils; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin | 2003 |
Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators.
Topics: Abciximab; Adenosine Diphosphate; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; Cell Degranulation; Collagen; Drug Interactions; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Oligopeptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12 | 2004 |
Acetylsalicylic acid inhibits ATP diphosphohydrolase activity by platelets from adult rats.
Topics: 5'-Nucleotidase; Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Apyrase; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; In Vitro Techniques; Male; Rats; Rosaniline Dyes | 2004 |
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Degranulation; Dalteparin; Drug Synergism; Heparin; Hirudins; Humans; In Vitro Techniques; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12 | 2005 |
P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Topics: Adenine; Adenosine Diphosphate; Adenosine Monophosphate; Adenylyl Cyclases; Aspirin; Blood Platelets; Collagen; Cyclic AMP; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Epinephrine; Epoprostenol; Humans; Membrane Proteins; Oligopeptides; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Signal Transduction; Thrombin; Time Factors; Tyrosine | 2005 |
Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents.
Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Monitoring; Eptifibatide; Hirudins; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Sensitivity and Specificity; Ticlopidine | 2005 |
Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD40 Ligand; Coagulants; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Receptors, Thrombin; Secretory Vesicles; Tirofiban; Tyrosine | 2005 |
Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Atherosclerosis; Blood Coagulation Tests; Blood Platelets; Carotid Stenosis; Dose-Response Relationship, Drug; Hemorheology; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Time Factors; von Willebrand Factor | 2007 |
Enhanced platelet aggregation and activation under conditions of hypothermia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Monophosphate; Anticoagulants; Antigens, CD; Aspirin; Blood Platelets; Blood Specimen Collection; Citrates; Cold Temperature; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Hirudins; Humans; Hypothermia, Induced; In Vitro Techniques; P-Selectin; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Platelet Membrane Glycoproteins; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Receptors, Thrombin; Tetraspanin 30; Time Factors | 2007 |
Antiplatelet therapy in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Thiophenes; Ticagrelor; Ticlopidine | 2008 |
Hydrolysis of adenine nucleotides in platelets from patients with acute myocardial infarction.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aspirin; Blood Platelets; Case-Control Studies; Clopidogrel; Female; Humans; Hydrolysis; Male; Middle Aged; Myocardial Infarction; Ticlopidine | 2008 |
Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adrenergic alpha-Antagonists; Aged; Aspirin; Blood Platelets; Clopidogrel; Collagen; Coronary Artery Disease; Drug Resistance; Drug Therapy, Combination; Female; Humans; Imidazoles; Male; Middle Aged; Norepinephrine; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, Adrenergic, alpha-2; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Failure | 2008 |
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.
Topics: Acrylamides; Adenosine Monophosphate; Aspirin; Atherosclerosis; Blood Platelets; Cells, Cultured; Dinoprostone; Drug Interactions; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Purinergic P2Y12; Sulfones | 2008 |
Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Ticlopidine; Treatment Outcome | 2009 |
Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Cardiovascular Diseases; Case-Control Studies; Clopidogrel; Drug Monitoring; Female; Flow Cytometry; Humans; Male; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Tissue Fixation | 2009 |
P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP.
Topics: Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Adhesion Molecules; Cyclic AMP; Humans; Microfilament Proteins; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins E; Purinergic P2Y Receptor Antagonists; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Purinergic P2Y12 | 2011 |
Cangrelor for treatment during percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Stents | 2014 |
Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.
Topics: Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Line, Tumor; Female; Flow Cytometry; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Real-Time Polymerase Chain Reaction; Receptors, Purinergic P2Y12 | 2015 |
Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adult; Animals; Aspirin; Blood Coagulation; Blood Platelets; Coronary Thrombosis; Dinucleoside Phosphates; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Rats, Sprague-Dawley; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Time Factors; Young Adult | 2016 |
A Case Report of Cangrelor Bridge Therapy for a Diagnostic Bronchoscopy With Biopsy.
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aged; Aspirin; Biopsy; Bronchoscopy; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Female; Hemorrhage; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2020 |
Effect of P2Y
Topics: Adenosine Monophosphate; Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Female; Fibrin Clot Lysis Time; Fibrinolysis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor | 2019 |
Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single-center pilot study.
Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Drug Therapy, Combination; Endovascular Procedures; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stents; Stroke; Thrombectomy; Treatment Outcome | 2019 |
Intravenous Antiplatelet Therapy Bridging in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention.
Topics: Adenosine Monophosphate; Administration, Intravenous; Aged; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Perioperative Care; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Time Factors; Tirofiban; Treatment Outcome | 2019 |
Bridging antiplatelet therapy with cangrelor in patients with recent intracranial stenting undergoing invasive procedures: a prospective case series.
Topics: Adenosine Monophosphate; Aspirin; Brain; Female; Fibrinolytic Agents; Humans; Intracranial Aneurysm; Intracranial Thrombosis; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents | 2019 |
Preliminary Experience with Cangrelor for Endovascular Treatment of Challenging Intracranial Aneurysms.
Topics: Adenosine Monophosphate; Aneurysm, Ruptured; Aspirin; Cerebral Angiography; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Purinergic P2Y Receptor Antagonists; Stents | 2020 |
Platelet Adhesion and Thrombus Formation in Microchannels: The Effect of Assay-Dependent Variables.
Topics: Adenosine Monophosphate; Aspirin; Blood Platelets; Collagen; Cyclooxygenase Inhibitors; Humans; Male; Microfluidics; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Young Adult | 2020 |
Efficacy of Cangrelor as Bridging Therapy Post PCI.
Topics: Adenosine Monophosphate; Aged; Aspirin; Colectomy; Colonic Neoplasms; Drug-Eluting Stents; Factor Xa Inhibitors; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Thrombosis; Ticagrelor | 2020 |
Antiplatelet Therapy During Emergent Extracranial Internal Carotid Artery Stenting: Comparison of Three Intravenous Antiplatelet Perioperative Strategies.
Topics: Abciximab; Adenosine Monophosphate; Administration, Intravenous; Aged; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Drug Administration Schedule; Emergencies; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Stents; Time Factors; Treatment Outcome | 2021 |
Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Aspirin; Blood Platelets; Coronary Artery Disease; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus; Disseminated Intravascular Coagulation; Drug Combinations; Female; Hospital Mortality; Humans; Hypertension; Iran; Lopinavir; Lung; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2021 |
D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Aspirin; COVID-19 Drug Treatment; Glycine; Humans; Lysine; SARS-CoV-2 | 2022 |
Aspirin Protects against UVB-Induced DNA Damage through Activation of AMP Kinase.
Topics: Adenosine Monophosphate; Adenylate Kinase; Animals; Aspirin; Cyclooxygenase Inhibitors; DNA Damage; HaCaT Cells; Humans; Inflammation; Keratinocytes; Mice; Mice, Inbred C57BL; Protein Kinases; Pyrimidine Dimers; Ultraviolet Rays | 2023 |
Dual antiplatelet therapy with aspirin and cangrelor and spinal anesthesia for a urological procedure.
Topics: Adenosine Monophosphate; Anesthesia, Spinal; Aspirin; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors | 2023 |